Mealey's (June 10, 2019, 10:09 AM EDT) -- WILMINGTON, Del. — Opioid maker Subsys Therapeutics Inc. on June 10 filed a voluntary petition for bankruptcy reorganization and said it intends to sell “substantially all” of the company’s assets and address its “legacy legal liabilities,” including $243 million owed to the United States and millions owed to 21 law firms that make up most of its top 30 unsecured creditors (In Re: Insys Therapeutics, Inc., No. 19-11292, D.Del. Bkcy., Del.)....